| Dec'17 | Dec'16 | |||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income (loss) | ||||||
-242 | -1,686 | |||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||
Interest on cash and cash equivalents held in Trust Account | ||||||
1,232 | 308 | |||||
Interest on convertible note to Sponsor | ||||||
18 | 0 | |||||
Provision for uncollectible other receivables | ||||||
278 | 278 | |||||
Changes in operating assets and liabilities: | ||||||
Prepaid expenses | ||||||
-10 | -78 | |||||
Other receivables | ||||||
-1 | 488 | |||||
Accounts payable and accrued expenses | ||||||
-4 | 1,442 | |||||
Net cash used in operating activities | ||||||
-817 | -479 | |||||
Cash released from Trust Account for redemption of common stock | ||||||
0 | 0 | |||||
Cash released from Trust Account - redemption of shares of common stock | ||||||
49,899 | 0 | |||||
Interest income released from Trust Account for franchise taxes | ||||||
226 | 216 | |||||
Net cash provided by investing activities | ||||||
50,126 | 216 | |||||
Cash flows from financing activities: | ||||||
Proceeds of convertible note received from Sponsor | ||||||
0 | 0 | |||||
Due to affiliate | ||||||
352 | 205 | |||||
Proceeds from issuance of common stock to initial stockholder | ||||||
0 | 0 | |||||
Proceeds from sale of Units, net of underwriting commissions paid | ||||||
0 | 0 | |||||
Proceeds from sale of over-allotment Units, net of underwriting commissions paid | ||||||
0 | 0 | |||||
Proceeds from sale of Private Placement Warrants | ||||||
0 | 0 | |||||
Payment of offering expenses | ||||||
0 | 0 | |||||
Proceeds from promissory note | ||||||
580 | 15 | |||||
Repayment of advances from affiliate and promissory note - related parties | ||||||
0 | 0 | |||||
Redemption of Units | ||||||
49,899 | 0 | |||||
Net cash (used in) provided by financing activities | ||||||
-49,319 | 15 | |||||
Decrease in cash | ||||||
-10 | -248 | |||||
Supplemental disclosure of noncash financing activities: | ||||||
Deferred underwriting fees | ||||||
0 | 0 | |||||
Payment of offering costs through advance from related party | ||||||
0 | 0 | |||||
Change in value of common stock subject to possible redemption | ||||||
-242 | -1,686 | |||||